rs35277569

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000522.5(HOXA13):​c.633G>T​(p.Met211Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000829 in 1,613,608 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M211L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0045 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00044 ( 6 hom. )

Consequence

HOXA13
NM_000522.5 missense

Scores

4
6
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 5.63

Publications

5 publications found
Variant links:
Genes affected
HOXA13 (HGNC:5102): (homeobox A13) In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally regulated during embryonic development. This gene is part of the A cluster on chromosome 7 and encodes a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. Expansion of a polyalanine tract in the encoded protein can cause hand-foot-uterus syndrome, also known as hand-foot-genital syndrome. [provided by RefSeq, Jul 2008]
HOTTIP (HGNC:37461): (HOXA distal transcript antisense RNA) This gene produces a long RNA in antisense to the HOXA gene cluster. This transcript may regulate expression of HOXA genes in cis. This gene is upregulated in tumors and is implicated in the promotion of cell proliferation. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008342475).
BP6
Variant 7-27199445-C-A is Benign according to our data. Variant chr7-27199445-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00454 (691/152288) while in subpopulation AFR AF = 0.0159 (661/41576). AF 95% confidence interval is 0.0149. There are 2 homozygotes in GnomAd4. There are 322 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 691 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HOXA13NM_000522.5 linkc.633G>T p.Met211Ile missense_variant Exon 1 of 2 ENST00000649031.1 NP_000513.2 P31271Q6DI00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HOXA13ENST00000649031.1 linkc.633G>T p.Met211Ile missense_variant Exon 1 of 2 NM_000522.5 ENSP00000497112.1 P31271
HOTTIPENST00000421733.1 linkn.167+704C>A intron_variant Intron 1 of 1 5
HOTTIPENST00000605136.7 linkn.92+115C>A intron_variant Intron 1 of 1 2
HOTTIPENST00000814985.1 linkn.229+268C>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00455
AC:
692
AN:
152170
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0160
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00122
AC:
303
AN:
247510
AF XY:
0.000831
show subpopulations
Gnomad AFR exome
AF:
0.0174
Gnomad AMR exome
AF:
0.000697
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000180
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000443
AC:
647
AN:
1461320
Hom.:
6
Cov.:
33
AF XY:
0.000334
AC XY:
243
AN XY:
726994
show subpopulations
African (AFR)
AF:
0.0169
AC:
565
AN:
33476
American (AMR)
AF:
0.000649
AC:
29
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52998
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1111920
Other (OTH)
AF:
0.000745
AC:
45
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00454
AC:
691
AN:
152288
Hom.:
2
Cov.:
32
AF XY:
0.00432
AC XY:
322
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0159
AC:
661
AN:
41576
American (AMR)
AF:
0.00137
AC:
21
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68010
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00114
Hom.:
4
Bravo
AF:
0.00509
ESP6500AA
AF:
0.0143
AC:
63
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00136
AC:
165
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.43
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.57
D;D
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
.;D
MetaRNN
Benign
0.0083
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Pathogenic
3.0
M;M
PhyloP100
5.6
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-2.9
.;D
REVEL
Benign
0.17
Sift
Benign
0.084
.;T
Sift4G
Benign
0.10
.;T
Polyphen
0.59
P;P
Vest4
0.57
MutPred
0.24
Loss of disorder (P = 0.0665);Loss of disorder (P = 0.0665);
MVP
0.42
ClinPred
0.046
T
GERP RS
3.1
Varity_R
0.36
gMVP
0.47
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35277569; hg19: chr7-27239064; API